Masimo completed the acquisition of LiDCO Group for £31m.

Masimo, an American manufacturer of noninvasive patient monitoring technologies, completed the acquisition of LiDCO Group, a United Kingdom-based supplier of non-invasive and minimally invasive hemodynamic monitoring equipment to hospitals, for £31m. "Masimo shares LiDCO's commitment to providing innovative, best-in-class monitoring solutions to support evidence-based clinical decisions to enhance patient safety and outcomes. I believe the complementary strategic fit between our respective technologies and businesses will enhance the prospects for LiDCO's customers as part of Masimo Corporation's global operations," Joe Kiani, Masimo CEO and Chairman.